Literature DB >> 24627065

[Cost analysis of18F-FDG PET-CT from the perspective of the Brazilian Unified National Health System as healthcare provider: a study in a public healthcare center in Rio de Janeiro, Brazil].

Rosângela Caetano1, Luciene Fontes Schluckebier2, Cláudia Regina Garcia Bastos1, Rondineli Mendes da Silva1, Michel Pontes Carneiro2, Jorge Wagner Esteves da Silva2, Aline Navega Biz1.   

Abstract

Positron emission tomography (PET) has been introduced recently in Brazil and requires costs analysis to support economic evaluation studies on its use. The current study analyzed the use of 18 F-FDG PET-CT and estimated its costs from the perspective of a public healthcare provider. The micro-costing technique was used, identifying, quantifying, and valuing all the inputs used to perform the procedure. Cost estimates considered 85 tests performed at the Brazilian National Cancer Institute from March to June 2012. Reference cases were defined as adult cancer patients, output of five tests per day, and one dose of 18 F-FDG per patient. Unit cost for the procedure was BRL 3,150.30 based on career wages under the Ministry of Science and Technology and BRL 2,927.19 based on Ministry of Health career wages. The factor with the heaviest cost impact was daily output of tests. Other factors that could impact the test's cost in public healthcare institutions were also examined.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24627065     DOI: 10.1590/0102-311X00016413

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  3 in total

1.  Budget impact from the incorporation of positron emission tomography - computed tomography for staging lung cancers.

Authors:  Aline Navega Biz; Rosângela Caetano
Journal:  Rev Saude Publica       Date:  2015-08-11       Impact factor: 2.106

2.  Estimated costs of advanced lung cancer care in a public reference hospital.

Authors:  Renata Erthal Knust; Margareth Crisóstomo Portela; Claudia Cristina de Aguiar Pereira; Guilherme Bastos Fortes
Journal:  Rev Saude Publica       Date:  2017-08-17       Impact factor: 2.106

Review 3.  Highlighting COVID-19: What the imaging exams show about the disease.

Authors:  Lorena Sousa de Carvalho; Ronaldo Teixeira da Silva Júnior; Bruna Vieira Silva Oliveira; Yasmin Silva de Miranda; Nara Lúcia Fonseca Rebouças; Matheus Sande Loureiro; Samuel Luca Rocha Pinheiro; Regiane Santos da Silva; Paulo Victor Silva Lima Medrado Correia; Maria José Souza Silva; Sabrina Neves Ribeiro; Filipe Antônio França da Silva; Breno Bittencourt de Brito; Maria Luísa Cordeiro Santos; Rafael Augusto Oliveira Sodré Leal; Márcio Vasconcelos Oliveira; Fabrício Freire de Melo
Journal:  World J Radiol       Date:  2021-05-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.